Beta-thalassemia
Open accessThe DOI matches its Crossref record; 4 of the 89 references it cites were found in a registry or an index, and 85 are not checked yet.
Abstract
Beta-thalassemia is caused by the reduced (beta) or absent (beta) synthesis of the beta globin chains of the hemoglobin tetramer. Three clinical and hematological conditions of increasing severity are recognized, i.e., the beta-thalassemia carrier state, thalassemia intermedia, and thalassemia major. The beta-thalassemia carrier state, which results from heterozygosity for beta-thalassemia, is clinically asymptomatic and is defined by specific hematological features. Thalassemia major is a severe transfusion-dependent anemia. Thalassemia intermedia comprehend a clinically and genotypically very heterogeneous group of thalassemia-like disorders, ranging in severity from the asymptomatic carrier state to the severe transfusion-dependent type. The clinical severity of beta-thalassemia is related to the extent of imbalance between the alpha and nonalpha globin chains. The beta globin (HBB) gene maps in the short arm of chromosome 11, in a region containing also the delta globin gene, the embryonic epsilon gene, the fetal A-gamma and G-gamma genes, and a pseudogene (psiB1). Beta-thalassemias are heterogeneous at the molecular level. More than 200 disease-causing mutations have been so far identified. The majority of mutations are single nucleotide substitutions, deletions, or insertions of oligonucleotides leading to frameshift. Rarely, beta-thalassemia results from gross gene deletion. In addition to the variation of the phenotype resulting from allelic heterogeneity at the beta globin locus, the phenotype of beta-thalassemia could also be modified by the action of genetic factors mapping outside the globin gene cluster and not influencing the fetal hemoglobin. Among these factors, the ones best delineated so far are those affecting bilirubin, iron, and bone metabolisms. Because of the high carrier rate for HBB mutations in certain populations and the availability of genetic counseling and prenatal diagnosis, population screening is ongoing in several at-risk populations in the Mediterranean. Population screening associated with genetic counseling was extremely useful by allowing couples at risk to make informed decision on their reproductive choices. Clinical management of thalassemia major consists in regular long-life red blood cell transfusions and iron chelation therapy to remove iron introduced in excess with transfusions. At present, the only definitive cure is bone marrow transplantation. Therapies under investigation are the induction of fetal hemoglobin with pharmacologic compounds and stem cell gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
Anderson, L. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2822 · Cited by 1,682
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,552
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
McGuire, W., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,169
Rund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Research works printed but not linked: 5
- Wheatherall DJ, Clegg JB. The thalassemia syndromes. 4th ed. Oxford, England: Blackwell Science Ltd, 2001.
- Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In: Scriver CR, Beaudet Al, Sly WS, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease (OMMBID). Chapter 101. New York, NY: McGraw-Hill, 2002. Available at: www.ommbid.com. Accessed December 31, 2007.
- Rees, 1998, Genetic influenes on bone disease in thalassemia, Blood, 92, S532a
- Dresner Pollak, 2000, Bone mineral metabolism in adults with beta thalassemia major and intermedia, Br J Haematol, 111, 902
- Galanello, 1990, Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosome, Blood, 15, 75:11747
Cited by
Items 401–500 of 721
Almasoudi, H. H. (2025) · Current Research in Translational Medicine · doi:10.1016/j.retram.2025.103513 · Cited by 9
National Approach to Premarital Diagnosis of Trait Thalassemia and Silent Carriers
Mirbehbahani, N. B., Rashidbaghan, A., Mazji, M., & Behnampour, N. (2013) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2013.42017 · Cited by 4
β-Globin Gene Mutations in Pediatric Patients with β-Thalassemia in the Region of Çukurova, Turkey
Güzelgül, F., Seydel, G. Ş., & Aksoy, K. (2020) · Hemoglobin · doi:10.1080/03630269.2020.1792489 · Cited by 5
Saeidnia, M., Fazeli, P., Farzi, A., Nezhad, M. A., Shabani-Borujeni, M., Erfani, M., Tamaddon, G., & Karimi, M. (2023) · Hemoglobin · doi:10.1080/03630269.2022.2158099 · Cited by 7
Pattern and clinical correlates of renal iron deposition in adult beta-thalassemia major patients
Meloni, A., Barbuto, L., Positano, V., Pistoia, L., Spasiano, A., Casini, T., Massei, F., Argento, C., Giovangrossi, P., Barone, A., et al. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01133-x · Cited by 6
Accelerated atherosclerosis in beta-thalassemia
Hurtado, J., Sellak, H., Joseph, G., Lewis, C., Naudin, C. R., Garcia, S., Wodicka, J. R., Archer, D. R., & Taylor, W. R. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00306.2023 · Cited by 4
Balcázar-Villarroel, M., Mancilla-Uribe, A., Navia-León, S., Carmine, F., Birditt, K. R., & Sandoval, C. (2024) · Diagnostics · doi:10.3390/diagnostics14212353 · Cited by 11
Mokgalaboni, K., Phoswa, W. N., Modjadji, P., & Lebelo, S. L. (2025) · Thalassemia Reports · doi:10.3390/thalassrep15030007 · Cited by 4
Durmaz, B., Özkınay, F., Önay, H., Karaca, E., Aydınok, Y., Tavmergen, E., Vrettou, C., Traeger‐Synodinos, J., & Kanavakis, E. (2012) · Hemoglobin · doi:10.3109/03630269.2012.675891 · Cited by 4
Scheps, K. G., Hasenahuer, M. A., Parisi, G. D., Fornasari, M. S., Pennesi, S. P., Erramouspe, B., Basack, F. N., Veber, S. E., Aversa, L. A., Elena, G. O., et al. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12456 · Cited by 4
Profile of β-Thalassemia and its Prenatal Diagnosis in Khorasan-E-Jonobi Province, Iran
Miri‐Moghaddam, E., & Zadeh–Vakili, A. (2012) · Hemoglobin · doi:10.3109/03630269.2012.712928 · Cited by 4
Fondazione G. Monasterio CNR-Regione Toscana, P., Vassalle, C., Meloni, A., Pistoia, L., & Pepe, A. (2017) · International Journal of Hematology and Therapy · doi:10.15436/2381-1404.17.017 · Cited by 4
Mutational Profile of Homozygousβ-Thalassemia in Rio de Janeiro, Brazil
Carrocini, G. C. S., Venâncio, L. P. R., Pessôa, V., Lobo, C. L. C., & Bonini-Domingos, C. R. (2017) · Hemoglobin · doi:10.1080/03630269.2017.1289958 · Cited by 4
Rareβ-Globin Gene Mutations in Pakistan
Hussain, A., Ahmed, S., Ali, N., Mailk, H. S., Anees, M., Chuahdry, A. H., & Ahmed, P. (2017) · Hemoglobin · doi:10.1080/03630269.2017.1339612 · Cited by 4
Tamaddoni, A., Astaneh, S. K., Tabaripour, R., & Akhavan‐Niaki, H. (2019) · Hemoglobin · doi:10.1080/03630269.2019.1567528 · Cited by 4
Makis, A. C., Georgiou, I. A., Traeger‐Synodinos, J., Storino, M. R., Giuliano, M., Andolfo, I., Hatzimichael, E. C., Chaliasos, N., Giapros, V. I., Izzo, P., et al. (2019) · Hemoglobin · doi:10.1080/03630269.2019.1699568 · Cited by 4
HBB mutations and HbA2 level: Escaping the carrier screening programs
Sharifi, A., & Mahdieh, N. (2020) · Clinical Case Reports · doi:10.1002/ccr3.3714 · Cited by 4
Goretti, L., Adiatmaja, C. O., & Kahar, H. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103826 · Cited by 4
Padeniya, P., Goonasekera, H. W. W., Abeysekera, G., Jayasekara, R. W., & Dissanayake, V. H. W. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.890989 · Cited by 4
Barati, Z., Farsimadan, M., Sharafshah, A., Peymani, M., & Bijanzadeh, M. (2019) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2018.1498514 · Cited by 4
Serum folate and cytokines in heterozygous β‐thalassemia
Paniz, C., Lucena, M. R., Bertinato, J. F., Santos, M. N. N., Gomes, G. W., Figueiredo, M. S., Sonati, M. D. F., Bláia-D'Avila, V., Green, R., & Guerra‐Shinohara, E. M. (2020) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13287 · Cited by 4
Scheps, K. G., Hasenahuer, M. A., Parisi, G. D., Targovnik, H. M., García, E., Veber, S. E., Crisp, R. L., Elena, G. O., Varela, V., & Fornasari, M. S. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13029 · Cited by 4
Hsu, G., Jones, A., & Thornton, B. (2019) · Pediatric Emergency Care · doi:10.1097/pec.0000000000001873 · Cited by 4
Weslati, R., Ouederni, M., Ruffo, G. B., Khaled, M. B., Kouki, R., Girgenti, C. D., Borsellino, Z., Sammartano, I., Gazzah, M. E., El-Bok, S., et al. (2019) · Annals of Human Biology · doi:10.1080/03014460.2019.1695936 · Cited by 4
CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cellsPreprint
Chung, J. E., Magis, W., Vu, J. T., Heo, S., Wartiovaara, K., Walters, M. C., Kurita, R., Nakamura, Y., Boffelli, D., Martin, D. I. K., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/335729 · Cited by 4
Baqar, M., Ahmed, J. M., Asim, M., Pradhan, N. A., & Altaf, S. (2024) · BMJ Public Health · doi:10.1136/bmjph-2024-001359 · Cited by 3
Baloochi, M., Fard, M.-R. A., Ordoni, R., Pendar, A., Eslahi, A. V., Badri, M., Dezhkam, A., Kalkali, M., Rahdar, H.-A., Mohammadi, M., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11243-4 · Cited by 5
Ye, D., Chen, M., Zhu, Y. J., Feng, X., Xu, L., & Huang, H. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01962-5 · Cited by 5
Clinical base editing for β-hemoglobinopathies across different genetic backgrounds
Liu, R., Lai, Y., Wang, L., Qian, X., Ma, X.-K., Li, Y., Yang, G., Shi, L., Li, Z., Wei, J., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.08.009 · Cited by 4
Wu, L.-S., Peng, Z., Lu, S., Tan, M., Rong, Y., Tian, R., Yang, Y., Chen, Y., & Chen, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7476 · Cited by 4
Minkley, M., MacLeod, P., Anderson, C. K., Nashmi, R., & Walter, P. B. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147066 · Cited by 3
Kim, S., Dhaheri, H. A., & Kim, S.-Y. (2022) · Thalassemia Reports · doi:10.3390/thalassrep12030016 · Cited by 3
Severe β‐thalassemia (Hb Zunyi) mimicking congenital dyserythropoietic anemia
Nagahama, J., Nishikawa, T., Nakamura, T., Nakagawa, S., Kodama, Y., Terazono, H., Wakamatsu, M., Muramatsu, H., Yamashiro, Y., Kanno, H., et al. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.30706 · Cited by 3
Cai, D.-L., Chan, Y., Kong, Y.-M., Liu, Y., Guo, Y. P., Cai, A.-Q., & Zhu, B. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176404 · Cited by 4
Calleja, Á. M. M., Lourenço, M., Macedo, M. L., Gaspar, R. R., Ribeiro, L., & Santos, A. L. (2024) · Anthropological Science · doi:10.1537/ase.231105 · Cited by 3
Marrow Fat‐Cortical Bone Relationship in β‐Thalassemia: A Study Using MRI
Ismail, U. N., Azlan, C. A., Khairullah, S., Azman, R. R., Omar, N. F., Shah, M. N. M., Jackson, N. M., & Ng, K. H. (2024) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29366 · Cited by 3
Samanta, A., Sen, S., Choudhuri, I., & Bhattacharyya, N. (2024) · Indian Journal of Public Health · doi:10.4103/ijph.ijph_356_23 · Cited by 3
Jarujareet, U., Wiratchawa, K., Petiwathayakorn, T., Koonyosying, P., Hantrakool, S., Srichairatanakool, S., & Intharah, T. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.107265 · Cited by 6
Characterization of theHBB: c.*233G > C Variant: No Evidence of aβ-Thalassemic Phenotype
Smith, D. L., Mitui, M., Park, J. Y., Luu, H. S., & Timmons, C. F. (2015) · Hemoglobin · doi:10.3109/03630269.2015.1101002 · Cited by 3
Gemmo, C., Breveglieri, G., Marzaro, G., Lampronti, I., Cosenza, L. C., Gasparello, J., Zuccato, C., Fabbri, E., Borgatti, M., Chilin, A., et al. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-01987-9 · Cited by 3
Στρατόπουλος, Α., Κολλιοπούλου, Α., Karamperis, K., John, A., Kydonopoulou, K., Esftathiou, G., Sgourou, A., Kourakli, A., Vlachaki, E., Chalkia, P., et al. (2019) · Pharmacogenomics · doi:10.2217/pgs-2019-0063 · Cited by 4
Treatment of Genetic Diseases: Current Trends in the Development of Biomedical Cell Products
Анатольевна, Р. О., Vodyakova, M. A., Melnikova, E. V., & Меркулов, В. А. (2019) · Biological Products Prevention Diagnosis Treatment · doi:10.30895/2221-996x-2019-19-4-225-232 · Cited by 3
Development of DNA controls for detection of β‐thalassemia mutations commonly found in Asian
Munkongdee, T., Nualkaew, T., Buasuwan, N., Hinna, N., Paiboonsukwong, K., Sripichai, O., Svasti, S., Winichagoon, P., Fucharoen, S., & Jearawiriyapaisarn, N. (2020) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13292 · Cited by 3
Kelkar, K., Ramanan, V., Anand, S. P., Majethia, P., Ranade, S., Patil, K. N., Gangodkar, P. V., Bapat, A. C., Pilankar, A., Sengaokar, V., et al. (2020) · Journal of Hematopathology · doi:10.1007/s12308-020-00414-8 · Cited by 3
Bone mineral density among Palestinian patients suffering from hemoglobinopathy disorders
Kharroubi, A., Karmi, B., Shamasneh, W., & Saba, E. (2020) · Archives of Osteoporosis · doi:10.1007/s11657-020-00853-x · Cited by 4
Redzuwan, Y. N. M., Assyuhada, M. G. S. N., Ghani, R. A., Za’ror, Y. S. M. A., Bahar, R., Azlan, M., Zulkafli, Z. B., & Saleh, R. M. (2021) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v20i3.52804 · Cited by 3
Shivappa, P., Bernhardt, G. V., Mufti, M. M., & Banu, A. (2021) · OnLine Journal of Biological Sciences · doi:10.3844/ojbsci.2021.280.284 · Cited by 3
Khan, M. B. N., Iftikhar, F., Ali, M., Danish, A., Shamsi, T. S., Musharraf, S. G., & Siddiqui, A. J. (2022) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2022.105195 · Cited by 3
Chamtouri, I., Khalifa, R., Besbès, H., Jomaa, W., Abdallah, W., Hamda, K. B., Chouchène, C., & Maatouk, F. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02597-w · Cited by 3
Tripathi, P. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106748 · Cited by 4
Vuong, V. V. H., Tran, T. H., Nguyen, P., Thi, N. N., Thi, P. L., Nguyet, D. T. M., Nguyen, M.-H., Bui, T., Ta, T. V., & Tran, V.-K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278539 · Cited by 3
Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
Malagù, M., Longo, F., Marchini, F., Sirugo, P., Capanni, A., Clò, S., Mari, E., Culcasi, M., & Bertini, M. (2023) · Biology · doi:10.3390/biology12040491 · Cited by 3
When a synonymous mutation breaks the silence in a thalassaemia patient
Gorivale, M. S., Sawant, P. M., Kargutkar, N., Hariharan, P., Thaker, P. H., Chiddarwar, A. S., & Nadkarni, A. H. (2023) · British Journal of Haematology · doi:10.1111/bjh.19115 · Cited by 4
Genome-wide methylation and gene-expression analyses in thalassemia
Zhang, W., Li, X., Yu, U., Huang, X., Wang, H., Lu, Y., Liu, S., & Zhang, J. (2024) · Aging · doi:10.18632/aging.206037 · Cited by 5
Hematological ratios and cytokine profiles in heterozygous beta-thalassemia
Ciceri, A., de Oliveira, L. E., Richter, A. L., de Carvalho, J. A. M., Lucena, M. R., Gomes, G. W., Figueiredo, M. S., Santos, M. N. N., Bláia-D'Avila, V., Cançado, R. D., et al. (2025) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2025.103845 · Cited by 6
Habeb, A. M., Deeb, A., Hamza, R. T., Iughetti, L., Jalaludin, M. Y., Muze, K., Oyenusi, E. E., Rodda, C. P., Singh, P., Skordis, N., et al. (2025) · Hormone Research in Paediatrics · doi:10.1159/000546904 · Cited by 9
A Novel -72 (T→A)β-Promoter Mutation Causing Slightly Elevated HbA2in a Vietnamese Heterozygote
Pirastru, M., Mereu, P., Nguyen, C., Nguyen, N. V., Nguyen, T. D., & Manca, L. (2017) · BioMed Research International · doi:10.1155/2017/4537409 · Cited by 3
Ekwattanakit, S., Riolueang, S., & Viprakasit, V. (2017) · Hematology · doi:10.1080/10245332.2017.1359899 · Cited by 3
Investigation of beta globin gene mutations in Syrian refugee patients with thalassemia major
Çevirici, H., Acıpayam, C., Yenilmez, E. D., Belen, F. B., Pekpak, E., Yaman, Y., & Tuli, A. (2019) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2018-0492 · Cited by 3
A Novel Mutation at HBB: c.91delA (Codon 30, –A) Causing β-Thalassemia in a Chinese Family
Jia, W., Wang, W., Zhu, H., & Chen, P. (2019) · Acta Haematologica · doi:10.1159/000499860 · Cited by 3
Elghobashy, Y., Assar, M. F., Mahmoud, A. A. S., Eltorgoman, A. M. A., & Elmasry, S. (2020) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2020.100836 · Cited by 3
Jeelani, W., Sher, U., & Ahmed, M. (2020) · Dental Press Journal of Orthodontics · doi:10.1590/2177-6709.25.6.26.e1-9.onl · Cited by 3
Sen, A., Seenappa, V., Chakrabarti, P., & Dolai, T. K. (2021) · Hemoglobin · doi:10.1080/03630269.2021.2011314 · Cited by 3
Ouragini, H., Haddad, F., Darragi, I., & Abbes, S. (2013) · Hematology · doi:10.1179/1607845413y.0000000096 · Cited by 3
A Family with γ-Thalassemia and High Hb A2Levels
Parmeggiani, G., Gualandi, F., Selvatici, R., Rimessi, P., Bigoni, S., Masieri, M. T., Dolcini, B., Venturoli, A., Cappabianca, M. P., Ferlini, A., et al. (2016) · Hemoglobin · doi:10.3109/03630269.2016.1148613 · Cited by 3
Cappellini, M. D. (2012) · Goldman's Cecil Medicine · doi:10.1016/b978-1-4377-1604-7.00165-2 · Cited by 3
Genetic Counselling for Mediterranean Anaemia in Post-war Greece
Barmpouti, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-51783-4_27 · Cited by 3
Hong, R., Chandola, U., & Zhang, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-15764-0 · Cited by 3
Pseudoxanthoma Elasticum-Like in β-Thalassemia Major, a matter of α-Klotho and Parathyroid Hormone?
Baldan, A., Giusti, A., Bosi, C., Malaventura, C., Forni, G., & Borgna‐Pignatti, C. (2017) · Hemoglobin · doi:10.1080/03630269.2017.1403927 · Cited by 3
A β-Thalassemia Trait with Two Mutations in Cis in a Chinese Family
Li, J., Jiang, F., Zhen, L., Tang, X., & Li, D. (2019) · Hemoglobin · doi:10.1080/03630269.2019.1686011 · Cited by 3
An Early Diagnosis of Thalassemia: A Boon to a Healthy Society
Nigam, N., Singh, P. K., Bhatnagar, S., Nigam, S. K., & Tripathi, A. K. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100357 · Cited by 6
Ricchi, P., Meloni, A., Costantini, S., Spasiano, A., Cinque, P., Gargiulo, B., Pepe, A., & Filosa, A. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04047-w · Cited by 3
Hemochromatosis in a β‐thalassemia minor patient with H63D homozygous mutation: A case report
Pokhrel, N. B., Khanal, S., Chapagain, P., Pokhrel, B., & Shrestha, A. (2020) · Clinical Case Reports · doi:10.1002/ccr3.3096 · Cited by 3
Shamoun, M., & Callaghan, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-49980-8_6 · Cited by 3
Hamidieh, A. A., Mohajeri‐Tehrani, M. R., Behfar, M., Vaghari-Meher, N., Alimoghaddam, K., Mohseni, F., Ghavamzadeh, A., Larijani, B. A., & Hamidi, Z. (2015) · Experimental and Clinical Transplantation · doi:10.6002/ect.2014.0178 · Cited by 3
Leveraging machine learning for risk assessment and prediction of inheriting genetic disorders
Ramaswamy, M., Senthilnathan, S., Saravanan, A. R. I., Snehal, M., & Siva, K. (2025) · Computational and Structural Biotechnology Reports · doi:10.1016/j.csbr.2025.100038 · Cited by 4
White matter microstructure abnormalities in thalassemia patients using TBSS analysis based on DTI
Yang, M., Chen, G., Luo, C., Tang, C., Peng, F., Kong, R., & Peng, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-99505-8 · Cited by 4
Zurlo, M., Finotti, A., Gamberini, M. R., & Gambari, R. (2025) · British Journal of Biomedical Science · doi:10.3389/bjbs.2025.14311 · Cited by 2
Mohammed, K. J., Mohammed, H. N. S., & Shalgam, D. O. (2025) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2025.033.4.25 · Cited by 3
Li, Y., Li, Z., Xu, S., Liu, X., Liu, S., Wang, X., Liu, M., & Zeng, H. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.01.036 · Cited by 2
Pongchaiyakul, C., Teawtrakul, N., Theerakulpisut, D., Sribenjalak, D., & Charoenngam, N. (2026) · Calcified Tissue International · doi:10.1007/s00223-026-01483-0 · Cited by 2
Hemoglobin—A Review of Structure, Mechanisms and Analysis in the Clinical Diagnostic Laboratory
Harris, N., Boothe, P., Mbatia, H., Winter, W. E., & Marin, M. J. (2026) · LabMed · doi:10.3390/labmed3020015 · Cited by 3
Marsella, M., Salvagno, G. L., Dolcini, B., Ferlini, A., Ravani, A., Harteveld, C. L., Giordano, P. C., & Borgna‐Pignatti, C. (2014) · Hemoglobin · doi:10.3109/03630269.2014.948186 · Cited by 2
Unexpected discovery of hemoglobinopathy C/β° thalassemia
Bouyarmane, W., Uwingabiye, J., Biaz, A., Rachid, A., Mechal, Y., Dami, A., Bouhsain, S., Ouzzif, Z., & Idrissi, S. E. (2018) · Clinical Case Reports · doi:10.1002/ccr3.1815 · Cited by 2
Decrease of Peripheral Monocyte Relative Number and Mean Platelet Volume in Iron Overloaded Mice
Ghozali, M., Praptama, S., Widyastuti, R., Panigoro, R., Setiabudiawan, B., Reniarti, L., & Syamsunarno, M. R. A. A. (2019) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1659 · Cited by 2
Effect of photodynamic therapy on gingival inflammation in patients with thalassemia
Asmari, D. A., & Khan, M. K. A. (2019) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2019.101595 · Cited by 2
Charitou, G., Tsertos, C., Parpottas, Y., Christou, S., Lederer, C. W., Phylactides, M., & Kleanthous, M. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129732 · Cited by 2
Gürel, D. İ., Aral, Y. Z., Akcan, M., Cartı, Ö., & Bozkurt, G. (2021) · Trends in Pediatrics · doi:10.5222/tp.2021.41713 · Cited by 2
Does size matter? Two new deletions in the HBB gene cause β0-thalassemia
Ropero, P., Fernández, F. A. G., Nieto, J. M., Recasens, V., Montañés, Á., Murúzabal, M. J., Sarasa, M., Fernández, C., Villegas, A., & Cuesta, C. B. (2022) · Annals of Hematology · doi:10.1007/s00277-022-04837-4 · Cited by 2
Grody, W. W., & Deignan, J. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812536-6.00006-7 · Cited by 3
Innovative and Needs-led research on β-thalassemia treatment methods
Dan, M.-O., Gutu, B.-I., Severin, E. M., & Tanase, V.-G. (2023) · Frontiers in Hematology · doi:10.3389/frhem.2022.1085952 · Cited by 2
dos Santos, D. L., Barreto, M., Kislaya, I., Mendonça, J., Machado, M. P., Lopes, P., Dias, C. M., & Faustino, P. (2023) · Acta Médica Portuguesa · doi:10.20344/amp.19162 · Cited by 5
Béta-thalassaemia, B12-vitamin-hiány és társuló komplementmediált hemolízis
Pethő, Á. G., Nagy, Z. F., Mezei, Z. A., Takács, I., & Demeter, J. (2023) · Orvosi Hetilap · doi:10.1556/650.2023.32769 · Cited by 2
Shabaan, H., Ahmed, S. S. A., Shalaby, M. A. B., & Fallah, A. A. E. (2023) · The Egyptian Journal of Haematology · doi:10.4103/ejh.ejh_22_22 · Cited by 2
Zamanian, A., Ahmidi, N., & Drton, M. (2023) · Statistics in Medicine · doi:10.1002/sim.9920 · Cited by 5
Rai, H. P., & Stuart, A. J. (2024) · Cureus · doi:10.7759/cureus.60275 · Cited by 2
Dominant Beta Thalassemia: A Very Rare Cause of Thalassemia in a Mediterranean Country
Coşkun, Ç., & Ünal, Ş. (2024) · Hemoglobin · doi:10.1080/03630269.2024.2386067 · Cited by 2
Addressing complexities in β-thalassemia care: a case series from a resource-limited setting
Adhikari, P. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002471 · Cited by 2
Mahmoudi, P. S., Kaveh-Ahangaran, R., Rostami, T., Hosseini, A. S., Vaezi, M., & Shahrami, B. (2024) · Journal of Medical Case Reports · doi:10.1186/s13256-024-04910-8 · Cited by 2
Meloni, A., Saba, L., Positano, V., Taccori, M., Pistoia, L., Marco, E. D., Sanna, P. M. G., Longo, F., Giovangrossi, P., Gerardi, C., et al. (2025) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-025-03352-7 · Cited by 2
Metadata
- Authors
- Cao, A., & Galanello, R.
- Affiliations
- National Research Council (IT)
- University of Cagliari (IT)
- Corresponding author
- Cao, Antonio
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 12
- Issue
- 2
- Pages
- 61-76
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W4210970197
- Cited by
- 722
- References
- 4
- Citations by year
- 2026: 43 · 2025: 48 · 2024: 63 · 2023: 61 · 2022: 60 · 2021: 66 · 2020: 69 · 2019: 64 · 2018: 48 · 2017: 58 · 2016: 52 · 2015: 24 · 2014: 14 · 2013: 20 · 2012: 15
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4370 d)
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- beta-thalassemia, beta-globin gene, HBB mutations, thalassemia major, thalassemia intermedia, transfusion-dependent anemia, iron chelation therapy, bone marrow transplantation, fetal hemoglobin induction, genetic counseling, prenatal diagnosis, chromosome 11
- MeSH terms
- Female, Multigene Family, Genetic Testing, Globins, Genetic Carrier Screening, Humans, Pregnancy, Prenatal Diagnosis, Bone Marrow Transplantation, beta-Thalassemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.